Biomarkers, electronic health records (EHR), genomic data, imaging data, labs, social media, wearable sensors, and more provide enormous new sources of RWD that can aid in new discoveries for the quality, efficacy, and safety of new drug therapies. By DAVID BLACKMAN Clinical research is in the midst of a data explosion, and that’s a good thing. Technological advances are enabling access to secure and de-identified data sources for researchers, and the optimization of this data holds enormous potential for conducting clinical trials more efficiently, both from a cost and timeline perspective. The incorporation of real-world data (RWD), data gathered from actual patient experiences, in many ways represents an important step toward a fundamentally better understanding of states of disease and health. Biomarkers, electronic health records (EHR), genomic data, imaging data, labs, social media, wearable sensors, and more provide enormous new sources of RWD that can aid in new discoveries for ...
Wearable Medical devices took the world by storm and have altered our way of life forever. In 2016 the market for wearables reached an estimated $2 billion and experts predict that this number will skyrocket to $6 billion by 2023.
Fitbit has generated yet another mHealth partnership in its bidding to make the fitness wearables a major component in connected health programs.
The US Army is testing a telemedicine-based platform designed to send critical data from the field to the hospital and enabling providers to prepare for incoming patients. The connected care service is used by health systems and EMS providers for better care coordination during emergencies.
Using nanotechnology, the research team developed tiny platinum nanomotors to target Zika and microbeads to bind the virus. When they are added to a sample containing Zika, a 3D complex is formed which moves in the presence of hydrogen peroxide. This unique motion signal can be perceived using a smartphone by attaching it to a cost-effective optical device. The 3D Zika complex moves rapidly compared to the slower movement of other non-target viruses.
Since teledentistry is still a relatively new concept, the association has been modeled as an advocacy group that can guide practitioners, help to develop best practices and ensure that technology is readily available for those wanting to use it.
Public locations have seen the deployment of six kiosks, called MedCenters, developed by MedAvail. These locations include grocery stores, pharmacies and clinics located in Phoenix and Tuscon partnering with Express Scripts. These MedCenters offer 24/7 access to online pharmacies and can be seen as a ‘pharma ATM’.
Los Angeles-based Cedars –Sinai Medical center and UCLA experimenters are describing that a (consumer-grade) Fitbit tracker can be used in some Remote patient Monitoring programs if health professionals know the clinical limitation of the mobile health wearables. The researchers outlined the 90-day study and concluded that the Fitbit data could be used to identify trends that call for health professional involvement
In November, FDA’s device center will select which app is welcomed into the program, and the selected will have amplified interactions with FDA during the progress of their products. FDA will grant the advanced device nomination to products that meet the permitted criteria without requiring a separate application.
According to an estimate by SNS Telecom & IT, the present vibrant ecosystem is bound to trigger the growth of the mHealth market at more than USD 28 billion in 2018. In spite of impediments presented by regulation, patient acceptance and privacy concerns, the sector is expected to clock a CAGR of around 30 percent over the next three years.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.